PFE
Pfizer Inc.
- Selling, general and administrative, 2025
- $13.8B
- YoY, 2025
- −6.4%
- 5-year CAGR
- +3.5%
- 10-year CAGR
- −0.7%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $13.8B | −6.4% |
| 2024 | $14.7B | −0.3% |
| 2023 | $14.8B | +8.0% |
| 2022 | $13.7B | +7.7% |
| 2021 | $12.7B | +9.5% |
| 2020 | $11.6B | −8.9% |
| 2019 | $12.7B | +0.9% |
| 2018 | $12.6B | −14.8% |
| 2017 | $14.8B | −0.3% |
| 2016 | $14.8B | +0.2% |
| 2015 | $14.8B | +5.1% |
| 2014 | $14.1B | −1.8% |
| 2013 | $14.4B | −5.4% |
| 2012 | $15.2B | −13.7% |
| 2011 | $17.6B | −7.3% |
| 2010 | $19.0B | +28.6% |
| 2009 | $14.8B | +1.5% |
| 2008 | $14.5B | −7.0% |
| 2007 | $15.6B | — |